We are live on ! Find out more
GVT

Genesee Valley Trust Portfolio holdings

AUM $246M
1-Year Est. Return 8.93%
This Fund
S&P 500
This Quarter Est. Return
+6.24%
1 Year Est. Return
+8.93%
3 Year Est. Return
+30.19%
5 Year Est. Return
+78.62%
10 Year Est. Return
AUM
$146K
AUM Growth
+$4.24K
Cap. Flow
+$955K
Cap. Flow %
654.36%
Top 10 Hldgs %
19.45%
Holding
239
New
12
Increased
63
Reduced
138
Closed
15

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$609K
2
STT icon
State Street
STT
+$603K
3
PEP icon
PepsiCo
PEP
+$376K
4
POOL icon
Pool Corp
POOL
+$360K
5
MMM icon
3M
MMM
+$308K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$927K
2
SJM icon
J.M. Smucker
SJM
+$288K
3
DD
Du Pont De Nemours E I
DD
+$281K
4
WFC icon
Wells Fargo
WFC
+$276K
5
JPM icon
JPMorgan Chase
JPM
+$273K

Sector Composition

Rank Sector Weight
1 Financials 16.74%
2 Technology 15.52%
3 Healthcare 14.01%
4 Industrials 9.73%
5 Consumer Discretionary 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
201
RTX Corp
RTX
$287B
-11,967
Closed -$825
TGT icon
202
Target
TGT
$62.1B
-5,304
Closed -$383
VZ icon
203
Verizon
VZ
$194B
-6,261
Closed -$333
WBS icon
204
Webster Financial
WBS
$12.3B
-4,157
Closed -$225
LBAI
205
DELISTED
Lakeland Bancorp Inc
LBAI
-10,123
Closed -$197
BEAV
206
DELISTED
B/E Aerospace Inc
BEAV
-5,737
Closed -$345
WOOF
207
DELISTED
VCA Inc.
WOOF
-5,077
Closed -$348

Similar funds

Genesee Valley Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Genesee Valley Trust held 239 positions worth $146K, up 3% from $142K the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Genesee Valley Trust deployed $955K of net new capital in Q1 2017, opening 12 new positions and adding to 63 existing holdings. Its largest new stake was State Street: 7,608 shares worth $605.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Merck, an estimated $927K trimmed.

  • Genesee Valley Trust's largest Q1 2017 buy was State Street: 7,608 shares worth $605.
  • Genesee Valley Trust added most to Regeneron Pharmaceuticals in Q1 2017, an estimated $609K increase.
  • Genesee Valley Trust's biggest Q1 2017 reduction was Merck, cutting an estimated $927K.
  • Genesee Valley Trust fully exited RTX Corp in Q1 2017, selling an estimated $825.
  • Genesee Valley Trust's ten largest holdings make up 19% of its $146K portfolio in Q1 2017.
  • Genesee Valley Trust opened 12 new positions and closed 15 in Q1 2017.
  • Genesee Valley Trust's portfolio value rose 3% quarter-over-quarter to $146K.

Based on Genesee Valley Trust's 13F filing for Q1 2017, filed 2 May 2017.